A61K 31/5517
Condensed with five-membered rings having nitrogen as a ring hetero atom
Official title: condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
A61K31/5517 (Condensed with five-membered rings having nitrogen as a ring hetero atom) appears on 622 US grants and 1,096 published applications in this corpus.
Search patents in A61K- Granted patents
- 622
- Published applications
- 1,096
- Assignees
- 438
- Inventors
- 1,686
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 2 | 0 |
| 2002 | 3 | 3 |
| 2003 | 3 | 29 |
| 2004 | 22 | 44 |
| 2005 | 4 | 9 |
| 2006 | 41 | 29 |
| 2007 | 3 | 16 |
| 2008 | 13 | 13 |
| 2009 | 9 | 20 |
| 2010 | 5 | 14 |
| 2011 | 5 | 18 |
| 2012 | 9 | 23 |
| 2013 | 9 | 27 |
| 2014 | 26 | 47 |
| 2015 | 29 | 55 |
| 2016 | 39 | 69 |
| 2017 | 43 | 91 |
| 2018 | 49 | 70 |
| 2019 | 64 | 78 |
| 2020 | 53 | 83 |
| 2021 | 36 | 68 |
| 2022 | 37 | 83 |
| 2023 | 31 | 62 |
| 2024 | 36 | 55 |
| 2025 | 28 | 37 |
| 2026 | 19 | 53 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Use of multikinase inhibitor6 Oct 2026US 12,751,957 B2Transthera Sciences (Nanjing), Inc.
- Treatment of inflammatory diseases of the central nervous system29 Sep 2026US 12,746,245 B2Palmaya Pty Ltd
- Degradation of Bruton's tyrosine kinase (BTK) by conjugation of BTK inhibitors with E3 ligase ligand and methods of use8 Sep 2026US 12,729,203 B2BeOne Medicines | GmbH
- Methods of controlling and improving brain health28 Jul 2026US 12,691,124 B2Icahn School of Medicine at Mount Sinai
- Combination of antibody-pyrrolobenzodiazepine derivative conjugate and PARP inhibitor9 Jun 2026US 12,648,946 B2Daiichi Sankyo Company, Limited
- Anti-HER2 Antibodies and Immunoconjugates1 Oct 2026US 2026/0297214 A1Genentech, Inc.
- Unit dosage composition comprising midazolam24 Sep 2026US 2026/0284075 A1
- Fused Ring Compound and Preparation Method Therefor and Use Thereof17 Sep 2026US 2026/0274865 A1Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
- Compositions and methods relating to use of agonists of alpha5-containing gabaa receptors10 Sep 2026US 2026/0263478 A1Centre for Addiction and Mental Health
- Arginine vasopressin receptor (avpr) antagonists and methods of using thereof10 Sep 2026US 2026/0265257 A1University of Miami
Most cited
By later US patents
- Delivery of erectile dysfunction drugs through an inhalation route120US 6,803,031 B2Alexza Molecular Delivery Corporation · 2004
- Delivery of opioids through an inhalation route113US 7,169,378 B2Alexza Pharmaceuticals, Inc. · 2007
- Delivery of opioids through an inhalation route107US 6,776,978 B2Alexza Molecular Delivery Corporation · 2004
- Delivery of drug esters through an inhalation route101US 7,070,765 B2Alexza Pharmaceuticals, Inc. · 2006
- Delivery of alprazolam, estazolam midazolam or triazolam through an inhalation route99US 7,018,619 B2Alexza Pharmaceuticals, Inc. · 2006